1361031-37-9

Basic information

• Product Name: 4-(2-dimethylaminoethyl)-1-(4-fluorophenyl)pyrazole-3-carboxylic acid
• Synonyms: 4-(2-dimethylaminoethyl)-1-(4-fluorophenyl)pyrazole-3-carboxylic acid
• CAS NO: 1361031-37-9
• Molecular Weight: 277.298
• Mol File: 1361031-37-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(2-dimethylaminoethyl)-1-(4-fluorophenyl)pyrazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-dimethylaminoethyl)-1-(4-fluorophenyl)pyrazole-3-carboxylic acid(1361031-37-9)
• EPA Substance Registry System: 4-(2-dimethylaminoethyl)-1-(4-fluorophenyl)pyrazole-3-carboxylic acid(1361031-37-9)

Safety Data

• Hazardous Substances Data: 1361031-37-9(Hazardous Substances Data)

Upstream product

• 1361031-17-5 ethyl 4-chloro-2-(4-fluorophenyl)azo-3-oxo-butanoate 
• 1361031-38-0 ethyl 4-(2-(dimethylamino)ethyl)-1-(4-fluorophenyl)-1H-pyrazole-3-carboxylate 
• 636568-08-6 ethyl 1-(4-fluorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylate 
• 371-40-4 4-fluoroaniline 

Downstream Products

• 1361030-62-7 N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-4-(2-(dimethylamino)ethyl)-1-(4-fluorophenyl)-1H-pyrazole-3-carboxamide 

Relevant articles and documents

Pharmaceutically active compounds as Axl inhibitors

The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I): and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.